Lactate Profile and Fat Oxidation During Exercise (LacFat)

September 12, 2023 updated by: Rocío Cupeiro, PhD, Technical University of Madrid

Relationship Between Lactate Profile and Fat Oxidation During Exercise

The goal of this clinical trial is to test whether changes in lactate kinetics during exercise (due to glycogen depletion or hyperthermia) alter the pattern of fat oxidation during a maximal incremental cycle ergometer test in healthy young active people. The main questions it aims to answer are:

  • Will a rightward shift in lactate kinetics, induced by a previous glycogen depletion, produce a rightward shift in fat oxidation?
  • Will a leftward shift in lactate kinetics due to an increase in ambient temperature produce a leftward shift in fat oxidation?

Participants will perform three maximal incremental tests in three different conditions:

  • one in the control condition;
  • one with glycogen depletion;
  • and one with ambient heat (the latter two in randomized, counterbalanced order).

Study Overview

Detailed Description

Introduction Lactate has three major functions: it is an energy substrate, it is a gluconeogenic precursor, and it is a signalling molecule (1). Among the signalling functions is that of modulating skeletal muscle metabolism, as a regulator of fat oxidation at both the autocrine and paracrine levels. At the autocrine level, lactate increases the levels of Acetyl-coenzyme A (CoA) inside the mitochondria and, consequently, the levels of Malonyl-CoA. The increase in Malonyl-CoA concentration inhibits Carnitine PalmitoylTransferase 1 (CPT1), which is one of the transporters of fatty acids into the mitochondria (2). At the paracrine level, an increase in blood lactate concentration reduces the release of fatty acids into the blood by adipose tissue (3). This occurs because the G protein-coupled receptor present in adipose tissue inhibits the release of fatty acids into the blood when the blood lactate concentration increases (4). However, in vivo, only an inverse correlation between blood lactate concentration and fatty acid oxidation has been demonstrated (5,6). Therefore, the main objective of the study is to observe whether the pattern of fat oxidation during a maximal incremental cycle ergometer trial is altered due to changes in lactate kinetics during the given trial. For this purpose, three maximal trials will be performed with the same loading protocol (intensity and progression of the same), but different physiological conditions (normal vs. previous glycogen depletion vs. environmental hyperthermia).

Procedures Consent to participate (signature of informed consent) will be requested from all volunteers who meet the inclusion criteria.

The tests that will be performed throughout this study will be the following:

  1. At the first appointment, you will be asked about your medical history. Then, if appropriate, an assessment of your body composition by dual X-ray absorptiometry (DEXA) will be performed,
  2. In the second appointment, spirometry, an electrocardiogram at rest, and finally, an ergospirometric trial will be performed.
  3. In the third, fourth, and fifth visits, three maximal exercise trials will be performed, one each day. Of the three maximum ergospirometric trials that will be performed, one will be in a hot environment -approximately 38º Celsius (ºC) ambient temperature- and the other in a state of glycogen depletion. A glycogen depletion protocol and a low-carbohydrate diet will be performed before the maximal ergospirometric trial in the glycogen-depleted state, while the other two trials (simple maximal trial and hot-environment maximal trial) will be performed after 24h of a high-carbohydrate diet.
  4. The order of performance of each protocol will be randomized, provided that the glycogen depletion protocol is performed at the visit prior to the maximal ergospirometric trial under glycogen depletion. The depletion protocol consists of a 60-minute continuous cycle ergometer effort at the power associated with 60% of the maximal oxygen uptake (VO2) followed by six 30-second maximal efforts with four minutes of recovery. After this glycogen depletion exercise protocol, the participant will follow a low-carbohydrate diet (2% carbohydrate, 78% fat, and 20% protein), until the time of the ergospirometric trial under glycogen depletion status.

Study Type

Interventional

Enrollment (Actual)

19

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Madrid, Spain, 28040
        • Laboratorio de Fisiología del Esfuerzo. Facultad de Ciencias de la Actividad Física y del Deporte (INEF)

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 40 years (Adult)

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Perform endurance training with a volume of between 3 and 12h/week
  • In women, having regular menstrual cycles (25-35 days length)
  • In women, being able to perform the test without menstrual discomfort or pain and without having taken anti-inflammatory or analgesic drugs

Exclusion Criteria:

  • Suffering from any previous disease, disorder or ailment that could affect the results of the study variables
  • Smoking
  • In women, using any type of hormonal contraceptive
  • In women, having heavy menstrual bleeding, detected with the menstrual bleeding questionnaire proposed by Wyatt et al. (2001)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Basic Science
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Control
Maximal test on a cycle ergometer
Maximal incremental exercise test on a cycle ergometer (5 min warm-up at 30W, and subsequent steps of 3 min with power increases of 30W)
Other Names:
  • Maximal incremental ergometry
Experimental: Hyperthermia
Maximal test on a cycle ergometer at 35º-38º C room temperature
Maximal incremental exercise test on a cycle ergometer (5 min warm-up at 30W, and subsequent steps of 3 min with power increases of 30W) performed at a room temperature of 35-38ºC (degrees Celsius).
Other Names:
  • Maximal incremental ergometry with hyperthermia
Experimental: Glycogen depletion
Maximal test on a cycle ergometer after a glycogen depletion protocol
Maximal incremental exercise test on a cycle ergometer (5 min warm-up at 30W, and subsequent steps of 3 min with power increases of 30W) under glycogen depletion by performing an exercise protocol to deplete glycogen stores plus a low-carbohydrate diet 24 h before incremental testing
Other Names:
  • Maximal incremental ergometry with glycogen depletion

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Blood lactate concentration
Time Frame: Through study completion, an average of 5 months
Lactate concentration, expressed in mMol/L (Millimoles Per Liter), measured in capillary blood using a lactate analyser. Lactate concentration is measured in the capillary blood extracted from the fingertip, during the tests performed in the different situations (control, glycogen depletion and hyperthermia)
Through study completion, an average of 5 months
Fat oxidation
Time Frame: Through study completion, an average of 5 months
Fat oxidation, expressed in g/min, is indirectly measured through the analysis of the gas composition of breathing (O2 and CO2), using a gas analyser. Fat oxidation is measured during the tests performed in the different situations (control, glycogen depletion and hyperthermia)
Through study completion, an average of 5 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Heart Rate
Time Frame: Through study completion, an average of 5 months
Heart rate, expressed in bpm (beats per minute), is measured using a pulsometer. Heart rate is measured during the tests performed in the different situations (control, glycogen depletion and hyperthermia)
Through study completion, an average of 5 months
Power output
Time Frame: Through study completion, an average of 5 months
Power output, expressed in watts, is measured with a cycle ergometer. Power output is measured during the tests performed in the different situations (control, glycogen depletion and hyperthermia)
Through study completion, an average of 5 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Rocío Cupeiro, PhD, Universidad Politécnica de Madrid.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 28, 2023

Primary Completion (Actual)

May 11, 2023

Study Completion (Actual)

May 11, 2023

Study Registration Dates

First Submitted

January 11, 2023

First Submitted That Met QC Criteria

January 26, 2023

First Posted (Actual)

January 27, 2023

Study Record Updates

Last Update Posted (Actual)

September 13, 2023

Last Update Submitted That Met QC Criteria

September 12, 2023

Last Verified

September 1, 2023

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Energy Metabolism

Clinical Trials on Incremental exercise test

Subscribe